Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Rogier Sanders and Andrew Ward.
Rogier Sanders
Connection Strength
1.262
Andrew Ward
  1. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. Cell. 2021 03 04; 184(5):1188-1200.e19.
    View in: PubMed
    Score: 0.232
  2. Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers. J Biol Chem. 2018 02 02; 293(5):1688-1701.
    View in: PubMed
    Score: 0.186
  3. Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo. J Exp Med. 2017 Sep 04; 214(9):2573-2590.
    View in: PubMed
    Score: 0.183
  4. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Science. 2021 08 13; 373(6556):818-823.
    View in: PubMed
    Score: 0.059
  5. A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection. Cell Host Microbe. 2021 05 12; 29(5):806-818.e6.
    View in: PubMed
    Score: 0.059
  6. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity. Immunity. 2020 12 15; 53(6):1272-1280.e5.
    View in: PubMed
    Score: 0.057
  7. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain. Cell Rep. 2020 10 20; 33(3):108274.
    View in: PubMed
    Score: 0.057
  8. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020 08 07; 369(6504):643-650.
    View in: PubMed
    Score: 0.055
  9. Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens. J Pharm Sci. 2019 07; 108(7):2264-2277.
    View in: PubMed
    Score: 0.051
  10. Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins. PLoS Pathog. 2018 05; 14(5):e1006986.
    View in: PubMed
    Score: 0.048
  11. Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. PLoS Pathog. 2018 02; 14(2):e1006913.
    View in: PubMed
    Score: 0.047
  12. Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages. J Proteome Res. 2018 03 02; 17(3):987-999.
    View in: PubMed
    Score: 0.047
  13. High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers. J Virol. 2017 11 15; 91(22).
    View in: PubMed
    Score: 0.046
  14. Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers. J Virol. 2017 08 01; 91(15).
    View in: PubMed
    Score: 0.045
  15. Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches. Immunity. 2017 06 20; 46(6):1073-1088.e6.
    View in: PubMed
    Score: 0.045
  16. Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes. J Virol. 2017 06 15; 91(12).
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.